Accel Research Sites-Birmingham Clinical Research Unit — Birmingham, Alabama

Accel Research Sites-Birmingham Clinical Research Unit is a clinical research site located in Birmingham, Alabama, United States 35216.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

Accel Research Sites-Birmingham Clinical Research Unit has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Rheumatoid Arthritis, Arthritis, Joint Diseases.

Sponsors: Eli Lilly and Company, Arena Pharmaceuticals, BioNTech SE.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Birmingham

Browse all research sites in Alabama · View every site in Birmingham

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accel Research Sites-Birmingham Clinical Research Unit?

Accel Research Sites-Birmingham Clinical Research Unit has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accel Research Sites-Birmingham Clinical Research Unit conducted?

Accel Research Sites-Birmingham Clinical Research Unit has 7 clinical trials on record, with 1 currently active. Their work covers Rheumatoid Arthritis, Arthritis, Joint Diseases.

Is Accel Research Sites-Birmingham Clinical Research Unit accredited by Crixeo Clinical Trials?

Accel Research Sites-Birmingham Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Accel Research Sites-Birmingham Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.